Technopath Clinical Diagnostics Holdings Limited

What Technopath Clinical Diagnostics Holdings Limited does

Technopath Clinical Diagnostics Holdings Limited is an Ireland-incorporated, privately held developer and manufacturer of third-party quality control (QC) materials and informatics software for clinical laboratories. The company's product portfolio centers on the Multichem line of frozen liquid stable QC materials covering clinical chemistry, immunoassay, cardiac markers (including the Multichem hsTn high-sensitivity troponin control), infectious disease, immunology, urine chemistry, diabetes, fertility, immunosuppressant drugs, coagulation, mass spectrometry and COVID-19 testing, alongside barcoded QC solutions for automated tracking. The IAMQC software platform provides peer-comparison reporting (IAMQC Peer) and next-generation QC management (IAMQC Infinity), enabling laboratories to benchmark QC results against global peers and automate monitoring for accreditation and regulatory compliance under CLIA, CLSI, CAP, ISO and RiliBÄK guidelines.

The company operates a hybrid go-to-market combining enterprise field sales to hospital networks and reference laboratories with a global product development, supply and distribution agreement with Abbott Diagnostics Division established in 2012, under which Technopath is the only Abbott-approved onboard third-party QC provider for Alinity ci systems. Direct distribution is supplemented by the My Technopath self-serve customer portal and channel reach through its parent LGC Clinical Diagnostics and sister brands such as Biosearch Technologies, Lucigen, Rapid Genomics and SeraCare. Revenue derives from one-time purchases of QC materials and IVD raw materials plus recurring subscription access to IAMQC software, with quote-based enterprise pricing on multi-year contracts.

Technopath was founded in 2008 with headquarters in Ballina, Ireland, and is now a wholly-owned subsidiary of LGC Clinical Diagnostics within the LGC Group following an acquisition that strengthened LGC's position in clinical quality controls. Named enterprise customers and reference accounts include Northwell Health (New York's largest healthcare provider, performing more than 30 million tests annually), PathCare (South Africa), and Ramon y Cajal Hospital (Madrid).

Name

Technopath Clinical Diagnostics Holdings Limited

Legal name

Technopath Clinical Diagnostics Holdings Limited

Website

https://technopathcd.com

Company type

Private

Founded year

2008

Operating status

Operating

Short description

Technopath Clinical Diagnostics is an Ireland-based, privately held manufacturer of third-party clinical laboratory quality control materials under the Multichem brand and QC informatics software under the IAMQC platform, serving hospital labs, reference labs and IVD manufacturers globally through Abbott distribution and direct sales.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostic Quality Controls

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Medical Equipment and Supplies Manufacturing (3391)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables) (HLAHAAAL)

akta.pro secondary industry

Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB)

Keywords

• Clinical diagnostics
• Quality control materials
• In vitro diagnostics
• Laboratory informatics
• Third party QC

Headquarters

HQ city

Ballina

HQ country

Ireland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Quality Control Materials: Sale of Multichem third-party quality control materials for clinical chemistry, immunoassay, cardiac, infectious disease, immunology, urine chemistry, diabetes, fertility, immunosuppressant, coagulation, mass spectrometry and COVID-19 testing applications
2. IAMQC Software Solutions: Subscription-based access to IAMQC Peer and Infinity software platforms for QC data management, peer comparison and automated QC monitoring
3. IVD Raw Materials: Supply of in vitro diagnostic raw materials to IVD manufacturers

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

Core offering

Technopath Clinical Diagnostics develops and manufactures third-party quality control materials (Multichem brand) in a frozen liquid stable format for clinical laboratories, covering immunoassay, clinical chemistry, cardiac, infectious disease, immunology, urine chemistry, diabetes, fertility, immunosuppressant, coagulation, COVID-19, and mass spectrometry testing. The company also provides IAMQC software solutions for quality control data management, peer comparison reporting, and automated QC monitoring. Additional offerings include in vitro diagnostic (IVD) raw materials supplied to diagnostic manufacturers.

Product overview

Technopath Clinical Diagnostics is a leading global developer and manufacturer of quality control (QC) materials and software solutions for clinical laboratories. The company's product portfolio centers on the Multichem® brand of third-party quality control materials, offered in a frozen liquid stable format, and the IAMQC® software platform for informatics and peer-based QC management. Multichem QC products cover extensive testing categories including cardiac (Multichem hsTn), immunoassay, clinical chemistry, infectious disease, immunology, urine chemistry, diabetes, fertility, immunosuppressant, coagulation, barcoded solutions, and mass spectrometry. The IAMQC platform provides complementary software solutions including IAMQC Peer for peer comparison reporting and IAMQC Infinity for next-generation QC informatics. The company also offers IVD raw materials. Technopath is the only Abbott-approved onboard third party QC provider for Alinity ci systems. The portfolio is designed to help clinical laboratories achieve cost-effective operations, meet accreditation and regulatory guidelines, and enhance confidence in clinical test results.

Differentiator

Problem solved

Functional benefit

Brands

• Multichem: Third-party quality control materials for clinical laboratories, including cardiac, immunoassay, clinical chemistry, infectious disease, immunology, urine chemistry, diabetes, fertility, immunosuppressant, coagulation, and mass spectrometry applications.
• IAMQC
• IAMQC Peer
• IAMQC Infinity

Products and services

• Multichem Quality Control Materials Comprehensive third-party QC materials for clinical laboratories covering multiple diagnostic testing categories, offered in a frozen liquid stable ready-to-use format that eliminates preparation time and improves consistency. Used by hospital laboratories, reference laboratories, and integrated healthcare networks for routine quality assurance.
• Multichem hsTn Third-party High Sensitive Troponin quality control material in a frozen liquid stable format, designed for cardiac marker testing quality control in clinical laboratories.
• Multichem Abbott Alinity QC Third-party quality control materials specifically approved for onboard use on Abbott Alinity ci analyzers, providing laboratories with an integrated onboard QC solution. Technopath is the only Abbott-approved onboard third party QC provider for these systems.
• Multichem AMH (Fertility) Quality control material specifically developed for Anti-Müllerian Hormone (AMH) fertility testing in clinical laboratories.
• Multichem D-Dimer (Coagulation) Quality control material for D-Dimer coagulation testing applications in clinical laboratories.
• Multichem COVID-19 Quality Controls Quality control materials specifically developed and validated for COVID-19 diagnostic testing in clinical laboratories.
• Multichem Mass Spectrometry QC Materials Quality control materials specifically designed for mass spectrometry testing applications in clinical laboratories.
• IAMQC Peer Cloud-based peer comparison software that enables clinical laboratories to compare their quality control results and performance against other institutions globally, supporting QA/QC review procedures and accreditation benchmarking.
• IAMQC Infinity Next-generation software solution within the IAMQC platform providing advanced QC informatics capabilities, automated QC management, monitoring, and reporting for clinical laboratories.
• IVD Raw Materials In vitro diagnostic raw materials supplied to IVD manufacturers for use in diagnostic product development, manufacturing, and kit production.

Quantifiable outcome

• Important savings in terms of time and costs while providing comparable analytical performance
• +2 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Three partnerships are on record, tiered flagship and core.

• Northwell HealthflagshipStrategic or Co-development Partner · 1 January 2017Established in 2017, Northwell Health is New York's largest healthcare provider. Northwell Health performs more than 30 million tests and analyzes 200,000 surgical specimens annually from its commercial lab service, hospitals, multiple outpatient facilities and over 40 blood-testing patient service centers. Technopath provides high-quality QC products for cost-effective clinical laboratory operations in the US market.
• Abbott Diagnostics DivisioncoreChannel Partner/ Reseller/ Distributor · 1 January 2012Global product development, supply and distribution agreement established in 2012. Abbott distributes Technopath's third-party quality controls alongside their diagnostic instrumentation. Abbott approves Technopath as the only onboard third party QC provider for Alinity ci systems. The partnership spans nearly a decade of collaboration.
• LGC Clinical DiagnosticsflagshipStrategic or Co-development PartnerTechnopath is part of LGC Clinical Diagnostics following acquisition. LGC Group is a global leader in the clinical diagnostics quality control market, providing Technopath with expanded resources and market reach across its portfolio including Biosearch Technologies, Lucigen, Rapid Genomics, and SeraCare brands.

Scale indicators6 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Siemens Healthineers: Siemens Healthineers (Atellica/ADVIA Centaur) sells its own QC consumables and informatics for clinical labs, positioning it as a broad incumbent against which Technopath competes for onboard QC status on non-Abbott platforms.
• Roche Diagnostics: Roche operates the cobas analyzer platform and offers its own QC ecosystem (PreciControl) alongside the broader diagnostics menu, competing with Technopath for onboard QC slots on Roche analyzers — a category where Technopath is currently Abbott-exclusive.
• Thermo Fisher Scientific: Through its Clinical Diagnostics and Analytical Instruments businesses, Thermo Fisher offers QC consumables, mass spectrometry QC standards, and clinical informatics, partially overlapping with Technopath's mass spec QC and IAMQC product lines.
• Beckman Coulter Diagnostics: Beckman Coulter (part of Danaher) manufactures clinical chemistry/immunoassay analyzers (DxI, Access) along with associated QC materials and informatics, representing a broad incumbent competing for onboard QC share on its installed base.
• Abbott Diagnostics: Abbott is both Technopath's exclusive global distribution partner (since 2012) and a competing analyzer/QC ecosystem via Alinity ci — making it a partner-cum-overlapping incumbent whose commercial decisions directly determine Technopath's addressable market on the largest installed base.

Direct peers

• Bio-Rad Laboratories: Bio-Rad's Clinical Diagnostics group is one of the largest global manufacturers of third-party quality control materials (Liquichek, Unity) for clinical chemistry, immunoassay, and specialty testing, directly competing with Technopath's Multichem portfolio for the same hospital and reference lab customers.
• Streck: Streck manufactures quality control and stabilization products for clinical and molecular diagnostics labs, including QC materials used on automated analyzers, overlapping with Multichem's third-party QC consumables offerings.
• Randox Laboratories: Randox produces the Acusera range of third-party QC materials spanning clinical chemistry, immunoassay, and specialty analytes, and operates RIQAS external quality assessment/proficiency testing — directly overlapping with Technopath's Multichem consumables and IAMQC peer-comparison programs.

Emerging players

• Diazyme Diagnostics: Diazyme specializes in clinical chemistry and immunoassay reagents and associated QC materials for clinical labs, providing overlapping offerings to Multichem in clinical chemistry/immunoassay QC.

Others

• SeraCare (LGC): SeraCare is a sister brand within LGC Clinical Diagnostics focused on reference materials and QC for molecular and infectious disease diagnostics — a complementary rather than directly competing peer that shares distribution and ownership with Technopath.

Market position

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/technopath-clinical-diagnostics

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Technopath Clinical Diagnostics Holdings Limited